Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eyes With Retinal Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04071977
What this trial is testing

Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients

Who this might be right for
Diabetic RetinopathyOxidative StressDiabetes
University of Guadalajara 40
Post-approval studies (Phase 4)Study completedNCT01223612
What this trial is testing

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

Who this might be right for
Diabetic Retinopathy
Moorfields Eye Hospital NHS Foundation Trust 37
Post-approval studies (Phase 4)Ended earlyNCT02002377
What this trial is testing

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

Who this might be right for
Age Related Macular Degeneration
Unity Health Toronto 23
Post-approval studies (Phase 4)Study completedNCT02930369
What this trial is testing

Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery

Who this might be right for
Macular Hole
Peking University People's Hospital 128
Not applicableLooking for participantsNCT06619405
What this trial is testing

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Who this might be right for
Age-Related Macular Degeneration
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT02186119
What this trial is testing

Abicipar Pegol in Patients With Diabetic Macular Edema

Who this might be right for
Macular Edema
Allergan 151
Not applicableEnded earlyNCT03894020
What this trial is testing

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+3 more
Gyroscope Therapeutics Limited 83
Testing effectiveness (Phase 2)Study completedNCT05637255
What this trial is testing

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Macular DegenerationNeovascular Age-related Macular DegenerationMacular Degeneration
Sylentis, S.A. 99
Not applicableEnded earlyNCT02994368
What this trial is testing

"Natural History" Study of Choroideremia

Who this might be right for
Choroideremia
4D Molecular Therapeutics 57
Not applicableStudy completedNCT06860568
What this trial is testing

The GA in HSI Study

Who this might be right for
Geographic AtrophyHealthy
Optina Diagnostics Inc. 42
Not applicableNot Yet RecruitingNCT06908161
What this trial is testing

Functional Assessments in Vision Impairment

Who this might be right for
Retinitis Pigmentosa (RP)Diabetic Retinopathy (DR)Age Related Macular Degeneration (AMD)+2 more
Center for Eye Research Australia 45
Testing effectiveness (Phase 2)Looking for participantsNCT06242379
What this trial is testing

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Mahidol University 15
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Not applicableUnknownNCT04419285
What this trial is testing

Mobility Protocol Adapted for Advanced Visually Impaired Subjects

Who this might be right for
Pigmentary Retinopathy
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 50
Large-scale testing (Phase 3)Study completedNCT04004208
What this trial is testing

Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy

Who this might be right for
Retinopathy of Prematurity (ROP)
Bayer 113
Not applicableUnknownNCT04000789
What this trial is testing

The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)

Who this might be right for
Non-Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy New Vessels on DiscDry Eye Syndromes
Dr Cipto Mangunkusumo General Hospital 96
Early research (Phase 1)Looking for participantsNCT06291935
What this trial is testing

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

Who this might be right for
Retinitis Pigmentosa
VeonGen Therapeutics GmbH 6
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT01710332
What this trial is testing

The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy

Who this might be right for
Central Serous Chorioretinopathy
Wills Eye 12
Early research (Phase 1)Study completedNCT03295877
What this trial is testing

Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Genentech, Inc. 28
Next Page